Opus Genetics (IRD) Cash from Investing Activities (2010 - 2024)

Opus Genetics (IRD) has 13 years of Cash from Investing Activities data on file, last reported at $1.2 million in Q4 2024.

• Cash from Investing Activities for Q4 2024 came in at $1.2 million, changed N/A year-over-year; the trailing twelve-month figure through Sep 2025 was $1.2 million (changed N/A YoY), and the FY2024 annual result was $1.2 million, changed N/A from the prior year.
• Cash from Investing Activities rose to $1.2 million in Q4 2024 per IRD's latest filing, from -$100000.0 in the prior quarter.
• Over five years, Cash from Investing Activities peaked at $1.2 million in Q4 2024 and troughed at -$100000.0 in Q4 2021.
• A 3-year average of $549666.7 and a median of $539000.0 in 2020 frame the typical range for Cash from Investing Activities.
• The sharpest annual moves came in 2020 and 2021: Cash from Investing Activities soared 536.26% in 2020, then slumped 118.55% in 2021.
• A 3-year view of Cash from Investing Activities shows it stood at $539000.0 in 2020, then tumbled by 118.55% to -$100000.0 in 2021, then jumped by 1310.0% to $1.2 million in 2024.
• Business Quant data shows IRD's Cash from Investing Activities at $1.2 million in Q4 2024, -$100000.0 in Q4 2021, and $539000.0 in Q4 2020.